期刊文献+

血β-羟丁酸测定在糖尿病酮症酸中毒诊断中的应用 被引量:1

Application of Serum β-hydroxybutyric Acid Determination in Diabetes Complicated with Keto Acidosis
下载PDF
导出
摘要 【目的】探讨β-羟丁酸的测定在糖尿病酮症酸中毒(DKA)的诊断及疗效观察中的意义。【方法】用酶法测定105例正常体检人员,86例糖尿病无酮症酸中毒患者和28例DKA血β-羟丁酸的浓度,同时测其血糖浓度的变化。比较28例治疗前后血β-羟丁酸浓度。【结果】糖尿病患者中血β羟丁酸较正常人明显升高(P<0.05),DKA患者血β-羟丁酸较正常人及糖尿病无酮症酸中毒患明显升高(P<0.01)。DKA患者治疗后血β-羟丁酸比治疗前明显降低(P<0.01)。【结论】血β-羟丁酸的测定可作为监测糖尿病进展有效指标;同时也是诊断DKA及观察其疗效的可靠指标。 [Objective]To evaluate the value of serum β- hydroxybutyric acid determination in diabetes complicated with acidosis. [Methods]The serum β- hydroxybutyric acid was determined with automatic enzy- matic assay tecniques in 105 routine medical examination patietns, 86 diabetes patients and 28 diabetes complicated with acidosis patients,at the same time, their serum glucose level was determined. β- hydroxybutyric acid level of 28 diabetes complicated with acidosis was compared before and after treatment. [Results]There existed significant rise of β- hydroxybutyric acid in diabetes than in routine medical examination patients( P〈0.05) . There existed more significant rise of β- hydroxyhutyric acid in diabetes complicated with acidosis than in diabetes without acidosis( P 〈0.01) . There existed more significant rise of β- hydroxybutyric acid in diabetes complicated with acidosis before teratment than after treatment( P 〈0.01) . [Conclusion]The β-hydroxbutyric acid is a valuable index in detecting progression of diabetes; and it is a reliable index in diagnosing diabetes compticated with ketoacidosis.
机构地区 湖南省人民医院
出处 《医学临床研究》 CAS 2007年第5期746-747,共2页 Journal of Clinical Research
关键词 糖尿痛酮症酸中毒/诊断 羟丁酸盐类/血液 diabetic ketoacidosis/DI hydroxybutyrates/BL
  • 相关文献

参考文献3

二级参考文献7

  • 1Li P K,Clin Chem,1980年,26卷,1713页
  • 2徐峰,上海医学检验杂志,1999年,14卷,2期,74页
  • 3傅祖植,内科学(第4版),1999年,716页
  • 4林其燧,临床化学诊断方法大全,1990年,82页
  • 5Chen AYW,cockram CS,Swaminathan R.Effect of delay in separating plasma for Glucose measurement upon the interpretation of oral glucose tests[].Am Clin Biochem.1990
  • 6Harric MI,Klein R,Wellborn TA.Onset at least 4-7 years before clinical diagnosis[].Diabetes Care.1992
  • 7Modan M,Harris MI.fasting plasma glucose in screening for NIDDM in the US and Israel[].Diabetes Care.1994

共引文献18

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部